secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0001636422-23-000034
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst appoints Carle Health COO Matthew Kolb to board; Carle becomes shareholder
--------------------------------------------------------------------------------

- Matthew Kolb, EVP & COO of Carle Health, appointed to board effective July 1, 2023, filling a newly created seat.
- Carle Health purchased HCAT common stock on open market, becoming a meaningful shareholder.
- Carle expanded client relationship in Dec 2022 with a five-year contract for tech-enabled managed services and all-access subscription.
- Carle paid ~$5.5M in 2022; 2023 payments expected to slightly exceed 5% of HCAT's projected revenue.
- Kolb will not receive director compensation beyond expense reimbursement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642223000034/0001636422-23-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642223000034/hcat-20230227.htm
  HTML page:      https://secwatch.observer/filing/0001636422-23-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer